Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.hlc.2020.07.005 http://scihub22266oqcxt.onion/10.1016/j.hlc.2020.07.005 32839114!7388894!32839114     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Heart+Lung+Circ 2020 ; 29 (9): e217-e221 Nephropedia Template TP {{tp|p=32839114|t=2020. CSANZ Position Statement on COVID-19 From the Paediatric and Congenital Council(?) |pdf=|usr=}}{{32839114}} gab.com Text CSANZ Position Statement on COVID-19 From the Paediatric and Congenital Council( ) JO: Heart Lung Circ http://www.kidney.de/pget.php?&tw=1&pmid=32839114 #FOAvip At the time of writing (25 May 2020), there have been nearly 4.4 million infections and 300,000 deaths worldwide related to COVID-19, an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Australia (currently 6,900 infections and 98 deaths) and New Zealand (1,500 infections and 21 deaths) have thus far been less affected than other regions. Risk factors for more severe disease include older age and pre-existing cardiovascular disease. The purposes of this document from the Paediatric and Congenital Council of the Cardiac Society of Australia and New Zealand (CSANZ) are to: 1) To review the mechanisms for cardiac involvement in COVID-19, specifically as they may impact patients with childhood and adult congenital heart disease (CHD); 2) To review the impact of SARS-CoV-2 infection in the paediatric population; 3) To review available data on the risks related to COVID-19 for childhood heart disease and adult CHD; 4) To provide guidance for childhood heart disease and adult CHD units in our Australasian region to re-organise services during the pandemic, so as to protect a highly specialised workforce and yet continue to provide an essential service; and 5) To review risk reduction strategies for acquiring COVID-19 for patients with childhood heart disease or adult CHD. Eleven (11) recommendations relevant to the care of children with heart disease and adults with CHD to mitigate the impact of COVID-19 are highlighted through the document. Twit Text FOAVip CSANZ Position Statement on COVID-19 From the Paediatric and Congenital Council( ) ????Heart Lung Circ http://www.kidney.de/pget.php?&tw=1&pmid=32839114 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32839114 #FOAvip English Wikipedia <ref>{{Cite pmid|32839114}}</ref> CSANZ Position Statement on COVID-19 From the Paediatric and Congenital Council(?) #MMPMID32839114 Ayer J; Anderson B; Gentles TL; Cordina RL Heart Lung Circ 2020[Sep]; 29 (9): e217-e221 PMID32839114show ga At the time of writing (25 May 2020), there have been nearly 4.4 million infections and 300,000 deaths worldwide related to COVID-19, an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Australia (currently 6,900 infections and 98 deaths) and New Zealand (1,500 infections and 21 deaths) have thus far been less affected than other regions. Risk factors for more severe disease include older age and pre-existing cardiovascular disease. The purposes of this document from the Paediatric and Congenital Council of the Cardiac Society of Australia and New Zealand (CSANZ) are to: 1) To review the mechanisms for cardiac involvement in COVID-19, specifically as they may impact patients with childhood and adult congenital heart disease (CHD); 2) To review the impact of SARS-CoV-2 infection in the paediatric population; 3) To review available data on the risks related to COVID-19 for childhood heart disease and adult CHD; 4) To provide guidance for childhood heart disease and adult CHD units in our Australasian region to re-organise services during the pandemic, so as to protect a highly specialised workforce and yet continue to provide an essential service; and 5) To review risk reduction strategies for acquiring COVID-19 for patients with childhood heart disease or adult CHD. Eleven (11) recommendations relevant to the care of children with heart disease and adults with CHD to mitigate the impact of COVID-19 are highlighted through the document. |Adult[MESH] |Age Factors[MESH] |Australia[MESH] |COVID-19[MESH] |Cardiovascular Diseases/diagnosis/*epidemiology/therapy[MESH] |Child[MESH] |Communicable Disease Control/*organization & administration[MESH] |Coronavirus Infections/epidemiology/*prevention & control[MESH] |Female[MESH] |Heart Defects, Congenital/diagnosis/*epidemiology/therapy[MESH] |Humans[MESH] |Infection Control/organization & administration[MESH] |Male[MESH] |New Zealand[MESH] |Pandemics/*prevention & control/statistics & numerical data[MESH] |Pneumonia, Viral/epidemiology/*prevention & control[MESH] |Practice Guidelines as Topic/*standards[MESH] |Prevalence[MESH] |Risk Assessment[MESH] |Sex Factors[MESH] |Societies, Medical[MESH] |Survival Analysis[MESH]CSANZ Position Statement on COVID-19 From the Paediatric and Congenita(epmc).pdf DeepDyve Pubget Overpricing